Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€6.40
11.01.21
€8.00
17.97%
25.01.21

Could be very worthwhile Investment >20% year
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€164.88
14.08.20
€210.00
04.11.21
24.94%
22.01.21

Future proof or reliable business model
Top 10 in its market
Innovative
Growths faster than the competition
buy
Asensus Surgical Inc.

Start price
Target price
Perf. (%)
€1.72
11.01.21
-
11.01.22
40.70%
19.01.21

Capable Management
Good culture
Dependend from some customers or products
buy
Humana Inc.

Start price
Target price
Perf. (%)
€364.00
03.11.20
-
04.11.21
-6.04%
14.01.21

Could be worthwhile Investment >10% per year
Differentiated customer and product portfolio
Higher risks for its business
buy
Nuwellis Inc.

Start price
Target price
Perf. (%)
€6.00
14.12.20
€8.00
14.12.21
6.67%
11.01.21

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€13.00
14.12.20
€25.00
14.12.21
71.15%
11.01.21

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€0.72
14.12.20
€2.00
14.12.21
9.69%
11.01.21

Could be worthwhile Investment >10% per year
buy
Avinger Inc.

Start price
Target price
Perf. (%)
€4.88
14.12.20
€20.00
301.64%
11.01.21

Could be worthwhile Investment >10% per year
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€4.36
13.12.20
-
13.12.21
-5.96%
10.01.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
buy
Agilent Technologies Inc.

Start price
Target price
Perf. (%)
€89.88
30.10.20
-
04.11.21
7.35%
03.01.21

Higher EBIT margin than peer group
Market Leader or Top 3
Known brand
Future proof or reliable business model
buy
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€371.00
29.10.20
-
04.11.21
8.65%
30.12.20

EBIT growth >5% per year expected
Very low/no dividend yield expected
buy
Inogen Inc.

Start price
Target price
Perf. (%)
€86.56
31.03.19
€108.24
04.11.21
-61.19%
21.12.20

buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
30.11.20
€7.00
30.11.21
-
14.12.20

Could be very worthwhile Investment >20% year
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€21.00
30.11.20
€25.00
30.11.21
-15.71%
14.12.20

Could be worthwhile Investment >10% per year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€13.50
30.11.20
€15.00
30.11.21
31.85%
14.12.20

Could be worthwhile Investment >10% per year
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€11.10
30.11.20
€14.00
30.11.21
-7.21%
14.12.20

Could be worthwhile Investment >10% per year
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
16.11.20
€7.00
16.11.21
-
30.11.20

Could be very worthwhile Investment >20% year
buy
Cutera Inc.

Start price
Target price
Perf. (%)
€18.10
16.11.20
€20.00
16.11.21
16.02%
30.11.20

Could be worthwhile Investment >10% per year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€13.20
16.11.20
€15.00
16.11.21
2.27%
30.11.20

Could be worthwhile Investment >10% per year
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€11.50
16.11.20
€13.00
16.11.21
-3.48%
30.11.20

Could be worthwhile Investment >10% per year
buy
CHF Solutions Inc

Start price
Target price
Perf. (%)
-
02.11.20
€8.00
04.11.21
-
16.11.20

Could be very worthwhile Investment >20% year
buy
Genmark Diagnostics

Start price
Target price
Perf. (%)
€10.90
02.11.20
€13.00
04.11.21
5.50%
16.11.20

Could be worthwhile Investment >10% per year
buy
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€11.40
02.11.20
€13.00
04.11.21
15.79%
16.11.20

Could be worthwhile Investment >10% per year
buy
Misonix Inc.

Start price
Target price
Perf. (%)
€9.55
02.11.20
€11.00
04.11.21
4.19%
16.11.20

Could be worthwhile Investment >10% per year
buy
LivaNova plc

Start price
Target price
Perf. (%)
€62.50
28.01.20
€100.00
04.11.21
-34.40%
09.11.20